Home » Analyst Articles – US

Image for Oppenheimer Issues Positive Forecast for Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price

Oppenheimer Issues Positive Forecast for Sensei Biotherapeutics (NASDAQ:SNSE) Stock Price

Sensei Biotherapeutics (NASDAQ:SNSE – Free Report) had its target price boosted by Oppenheimer from $3.50 to $4.00 in a research report report published on Friday morning,Benzinga reports. The firm currently has an outperform... More of this article »
Image for Tempest Therapeutics (NASDAQ:TPST) Given New $7.00 Price Target at Scotiabank

Tempest Therapeutics (NASDAQ:TPST) Given New $7.00 Price Target at Scotiabank

Tempest Therapeutics (NASDAQ:TPST – Free Report) had its price objective decreased by Scotiabank from $13.00 to $7.00 in a research report report published on Friday,Benzinga reports. Scotiabank currently has a sector outperform... More of this article »
Image for Wells Fargo & Company Issues Pessimistic Forecast for Northern Trust (NASDAQ:NTRS) Stock Price

Wells Fargo & Company Issues Pessimistic Forecast for Northern Trust (NASDAQ:NTRS) Stock Price

Northern Trust (NASDAQ:NTRS – Free Report) had its price target reduced by Wells Fargo & Company from $119.00 to $118.00 in a report issued on Friday,Benzinga reports. They currently have an equal weight rating on the asset... More of this article »
Image for Edap Tms (NASDAQ:EDAP) Price Target Lowered to $4.50 at Piper Sandler

Edap Tms (NASDAQ:EDAP) Price Target Lowered to $4.50 at Piper Sandler

Edap Tms (NASDAQ:EDAP – Free Report) had its price target lowered by Piper Sandler from $5.00 to $4.50 in a research note published on Friday,Benzinga reports. The brokerage currently has an overweight rating on the medical equipment... More of this article »
Image for Bausch + Lomb (NYSE:BLCO) Receives Equal Weight Rating from Wells Fargo & Company

Bausch + Lomb (NYSE:BLCO) Receives Equal Weight Rating from Wells Fargo & Company

Wells Fargo & Company reiterated their equal weight rating on shares of Bausch + Lomb (NYSE:BLCO – Free Report) in a report issued on Friday morning, MarketBeat.com reports. They currently have a $15.00 price objective... More of this article »
Image for Lululemon Athletica (NASDAQ:LULU) Price Target Lowered to $420.00 at BTIG Research

Lululemon Athletica (NASDAQ:LULU) Price Target Lowered to $420.00 at BTIG Research

Lululemon Athletica (NASDAQ:LULU – Free Report) had its price objective decreased by BTIG Research from $470.00 to $420.00 in a research report sent to investors on Friday morning,BayStreet.CA reports. BTIG Research currently... More of this article »
Image for Lululemon Athletica (NASDAQ:LULU) Given New $309.00 Price Target at Barclays

Lululemon Athletica (NASDAQ:LULU) Given New $309.00 Price Target at Barclays

Lululemon Athletica (NASDAQ:LULU – Free Report) had its price objective trimmed by Barclays from $411.00 to $309.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has an equal weight rating on... More of this article »
Image for Lululemon Athletica (NASDAQ:LULU) Given a $330.00 Price Target at Citigroup

Lululemon Athletica (NASDAQ:LULU) Given a $330.00 Price Target at Citigroup

Citigroup set a $330.00 price target on Lululemon Athletica (NASDAQ:LULU – Free Report) in a research note released on Friday morning,BayStreet.CA reports. The firm currently has a negative rating on the apparel retailer’s... More of this article »
Image for Truist Financial Cuts Lululemon Athletica (NASDAQ:LULU) Price Target to $380.00

Truist Financial Cuts Lululemon Athletica (NASDAQ:LULU) Price Target to $380.00

Lululemon Athletica (NASDAQ:LULU – Free Report) had its price target lowered by Truist Financial from $460.00 to $380.00 in a research note published on Friday, Marketbeat Ratings reports. The brokerage currently has a buy rating... More of this article »
Image for Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $108.00

Soleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $108.00

Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its price target hoisted by Stifel Nicolaus from $74.00 to $108.00 in a research note issued to investors on Friday,Benzinga reports. Stifel Nicolaus currently has a buy rating... More of this article »